We examined the relationship between endocrine, clinical and metabolic parameters in 35 women (mean age 27.3 years) with polycystic ovary syndrome (PCOS) and 30 age-and body mass indexmatched normal ovulatory women. In PCOS women, serum leptin, homocysteine, insulin, insulin-like growth factor-1, insulin-like growth factor binding protein-3 levels and the insulin resistance index (HOMA-IR) were significantly higher, while sex hormonebinding globulin and high-density lipoprotein cholesterol levels were lower compared with healthy women. Serum luteinizing hormone (LH), estradiol (E 2 ), androstenedione, testosterone and dehydroepiandrosterone sulphate levels were found to be significantly higher in PCOS women compared with healthy women. The levels of E 2 , LH and testosterone were positively correlated with leptin levels in PCOS women. Similarly, androstenedione levels and HOMA-IR were positively correlated with homocysteine levels and insulin levels were positively correlated with LH. We conclude that increased homocysteine levels, hyperandrogenaemia, insulin resistance and impaired lipid metabolism contribute to the risk of premature atherosclerosis in PCOS women.
Introduction
Polycystic ovary syndrome (PCOS) affects approximately 6 -10% of women of reproductive age and is characterized by ovarian dysfunction, hirsutism, hyperandrogenism, insulin resistance and obesity. 1 -3 Patients with PCOS have elevated cardiovascular risk factors, especially lipoproteins, blood pressure, clotting factors *Presented in part at the 7th International Congress on Coronary Artery Disease -from Prevention to Intervention, Venice, Italy, 7 -10 October 2007.
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and hyperinsulinaemia, and decreased reproductive potential. 2, 3 Hyperinsulinaemic insulin resistance is a key feature of PCOS and evidence suggests that hyperinsulinaemia plays a pathogenic role in the disorder by increasing circulating ovarian androgen concentrations and impeding ovulation. 4 Growth factors, such as insulin-like growth factor-1 (IGF-1) and insulin-like growth factor binding protein-3 (IGFBP-3), have been shown to play an important role in the regulation of ovarian follicular maturation and steroidogenesis. 5, 6 Previous studies have shown that the direct and indirect effects of IGF-1 and IGFBPs are independently associated with atherosclerotic plaque formation. 7, 8 Lipoprotein abnormalities appear to be associated more with insulin than with endogenous androgens or oestrogens. 3 Higher triglyceride and lower high-density lipoprotein (HDL) cholesterol levels correlate with insulin sensitivity in obese PCOS patients. 2 The reasons for the increased risk of coronary artery disease in PCOS are not completely known. The discovery of leptin opened up new perspectives to explain the relationship between body fat and menstrual disorders. 1 Leptin receptors have been identified in both granulosa and theca cells of the human ovarian follicle; granulosa cells have also been shown to secrete leptin, which indicates a direct paracrine role for leptin at the ovarian follicular level. 9 Some researchers have reported that leptin might have a role to play in reproductive physiology and the pathogenesis of PCOS. 10, 11 The role of leptin in the control of reproduction is unclear.
Clinical studies have demonstrated that hyperhomocysteinaemia may contribute to the development of cardiovascular diseases in PCOS patients. 12 -14 Badawy et al. 15 suggested that there was a strong association between serum homocysteine levels and insulin resistance in women with PCOS, however, the relationship between homocysteine and leptin, insulin resistance, lipoprotein metabolites, sex steroids and growth factors in patients with PCOS remains controversial. In the present study we aimed, therefore, to assess the relationship between serum homocysteine and leptin levels, and a range of other endocrine, clinical and metabolic parameters in women with PCOS.
Patients and methods

PATIENT POPULATION
Women of reproductive age with PCOS and normal ovulatory women who were ageand body mass index (BMI)-matched were recruited from the Department of Obstetrics and Gynaecology, Faculty of Medicine, Dicle University (Diyarbakir, Turkey) over a 10month period between March 2004 and January 2005. PCOS was diagnosed using clinical and/or biochemical signs of hyperandrogenism (increased serum total testosterone or free androgen index), oligomenorrhoea (six or fewer menses per year) or amenorrhoea (no menses in the last 6 months), and polycystic ovaries (by ultrasonographic examination). 16 All patients had normal prolactin levels and normal thyroid function test results. Patients had not taken any medication for the 3 months preceding the study. The healthy control women were volunteers who freely agreed to participate in the study. Exclusion criteria included impaired fasting glucose, diabetes mellitus, hypopituitarism, prolactinoma, active thyroid disease, anorexia nervosa and hepatic or haematological disease. The analyses were carried out during the early follicular phase (days 1 -5) in women who had menstrual A Atamer, B Demir, G Bayhan et al.
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cycles and in any phase of the cycle in the amenorrhoeic PCOS patients. The BMI was calculated using the standard formula of weight (kg) / height (m 2 ) and the waist/hip ratio was determined. All patients provided signed informed consent. The procedures that were followed were in accordance with the ethical standards for human experimentation established by the Declaration of Helsinki and the study was approved by the ethics committee of Firat University Medical Faculty.
BIOCHEMICAL ANALYSES
Blood samples were taken in the morning at 09:00 h after a 12-h overnight fast and centrifuged immediately. The serum was separated and frozen at -70 o C until assayed.
The serum leptin level was measured using an enzyme immunoassay kit (lot number 14425 A; Cayman Chemical, Ann Arbor, MI, USA). The intra-assay coefficient of variation (CV) was 6.1% (n = 8) at 7.6 ng/ml and 2.3% (n = 8) at 20.12 ng/ml.
The serum sex hormone-binding globulin (SHBG) level was determined by chemiluminescence on an Immulite analyser (Diagnostic Product Corporation, Los Angeles, CA, USA). The intra-and interassay CVs were 6.6% at 5.3 nmol/l and 5.2% at 3.3 nmol/l, respectively. Levels of serum total testosterone, estradiol (E 2 ), dehydroepiandrosterone sulphate (DHEAS), luteinizing hormone (LH) and folliclestimulating hormone (FSH) were measured by chemiluminescence on the Roche Elecsys 1010 and Modular Analytics E170 immunoassay analyser system (Elecsys Module; Roche Diagnostics, Mannheim, Germany). The intra-assay CVs of the assays used were as follows: testosterone 7.4% at 0.24 ng/ml; E 2 6.2% at 34.8 pg/ml; DHEAS 36% at 3.28 mg/dl; LH 5.2% at 0.03 mIU /ml; and FSH 5.3% at 0.06 mIU/ml. The level of serum androstenedione was measured by radioimmunoassay (RIA) using a commercially available iodine 125-labelled androstenedione RIA kit (Diagnostic Systems Laboratories Inc., Webster, TX, USA). The intra-assay CV was 5.6% (n = 12) at 0.71 ng/ml. The serum homocysteine level was measured using high-performance liquid chromatography with fluorescence detection (Shimadzu RF-10A fluorescence detector; Shimadzu Co., Kyoto, Japan).
The lipoprotein(a) (Lp[a]) level was measured by a nephelometric agglutination assay (N latex Lp[a] Reagent; Dade Behring Inc., Newark, DE, USA). Serum levels of total cholesterol, triglycerides (TG), HDL cholesterol and low-density lipoprotein (LDL) cholesterol were determined using an Aeroset autoanalyser (Abbott Laboratories Inc., Abbott Park, North Chicago, IL , USA). Levels of serum apolipoprotein A-1 (ApoA-1) and ApoB were evaluated by nephelometric assays using antiserum specific for ApoA-1 and ApoB (Dade Behring Inc.).
Levels of IGF-1 and IGFBP-3 were measured by two-site immunoradiometric assay (Diagnostic Systems Laboratories, Inc.). For IGF-1, the sensitivity was 0.8 ng/ml, and the intra-and inter-assay coefficients of variation were 3.8% and 4.9%, respectively. For IGFBP-3, the sensitivity was 0.8 ng/ml, and the intra-and inter-assay coefficients of variation were 5.6% and 7.1%, respectively.
Serum insulin was measured by electrochemiluminescence immunoassay with the Roche Elecsys 1010 and Modular Analytics E170 analysers (Roche Diagnostics). The minimum detection limit was 0.2 µU/ml and the intra-assay coefficient of variation was 4.9%. Insulin sensitivity was modelled according to a homeostasis model assessment (HOMA) computer-solved model. The insulin resistance index (HOMA-IR) was calculated with the formula: 17 HOMA-IR = fasting insulin (µU/ml) x fasting glucose (mmol/l) / 22.5.
STATISTICAL ANALYSIS
Statistical calculations were performed using the SPSS for Windows ® computer program (release 10.01; SPSS Inc., Chicago, IL, USA). All data are expressed as the mean ± SD. Differences between the study groups were analysed using an unpaired Student's t-test. Correlations were determined by Pearson's simple linear regression analysis (only significant correlation coefficients are reported). A P-value < 0.05 was taken to be statistically significant.
Results
Thirty-five women of reproductive age (mean ± SD: 27.3 ± 8.3 years; range 16 -41 years) with PCOS and 30 age-and BMImatched normal ovulatory women were recruited to the study. Their clinical, hormonal and biochemical parameters are given in Table 1 . The data confirm that the healthy control women were well matched 
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with the PCOS patients for age, BMI and waist/hip ratio (Table 1) . Serum levels of leptin, homocysteine, insulin, IGF-1, IGFBP-3 and HOMA-IR in women with PCOS were significantly higher than the levels in healthy women (P < 0.001), while the serum TG, total cholesterol, LDL cholesterol, ApoB and FSH levels were not significantly different from healthy control women. Serum levels of SHBG, ApoA-1 and HDL cholesterol were significantly lower in the patients with PCOS than in healthy women (P < 0.001), however, the level of Lp(a) was significantly higher in PCOS than in healthy women (P < 0.001). The LH, E 2 , androstenedione, testosterone and DHEAS levels were significantly higher (P < 0.001) in women with PCOS compared with healthy women. Serum levels of leptin showed a significant positive correlation with E 2 (r = 0.773; P < 0.01), LH (r = 0.828; P < 0.01) and testosterone (r = 0.809; P < 0.01) ( Fig. 1) . Insulin levels in the PCOS patients showed a significant positive correlation with LH (r = 0.536; P < 0.05) (Fig. 2) . Similarly, positive correlations were noted between homocysteine and HOMA-IR (r = 0.893; P < 0.01) and homocysteine and androstenedione levels (r = 0.934; P < 0.01) ( Fig. 3 ). All correlations are in women with PCOS only.
Discussion
The high frequency of certain cardiovascular risk factors, such as obesity, hyperinsulinaemia, hyperandrogenaemia, insulin resistance, dyslipidaemia and hyperhomocysteinaemia, and coronary artery disease in women with PCOS suggests that this illness leads to metabolic, endocrinological and cardiovascular disorders. 18, 19 In the present study, we observed that women with PCOS had higher leptin, insulin, HOMA-IR, LH, E 2 , androstenedione, testosterone, DHEAS and LH/FSH ratio, and lower levels of SHBG than healthy women. In PCOS patients, high levels of androgenic hormones interfere with the pituitaryovarian axis, leading to increased LH levels, anovulation, amenorrhoea and infertility. 20 Insulin resistance, not BMI, is the main determinant of hyperleptinaemia. Leptin has been thought to play a facilitatory role in ovulation and a contributory role in the promotion of pregnancy. 9 High leptin levels may also have a role to play in the pathophysiology of PCOS at the level of gonadotropin-releasing hormone neurons, pituitary gonadotrophs, or the ovaries. 10 Indeed, our data support the possibility of an important role for circulating leptin in the pathogenesis of impaired ovulation and the arrest of follicular development observed in PCOS. Topcu et al. 19 reported that patients with PCOS had higher levels of insulin, LH, androstenedione, testosterone, homocysteine, LH/FSH ratio and HOMA-IR than healthy women, suggesting that, in young women with PCOS and without cardiovascular risk factors, coronary flow reserve could be preserved. Acien et al. 21 reported that serum levels of insulin, androgens and BMI are related in women both with and without PCOS. Our findings are similar to reports from some investigators, 1, 22, 23 whilst other research has suggested that there are no differences. 24 It has been suggested that leptin may indirectly influence ovarian follicular activity by affecting LH release. 9 In addition, leptin could act on the pituitary-ovarian axis during fasting to improve reproductive function by partly stimulating oestrogen secretion. 1 Insulin has been shown to have an effect on leptin synthesis, 5, 9 however, in PCOS, the exact cause of basal insulin hypersecretion is not completely understood. SHBG alone has been variously reported as a good surrogate A Atamer, B Demir, G Bayhan et al. 25 and insulin is a direct negative regulator of hepatic SHBG production. 5 Hyperinsulinaemia is associated with androgen excess and a depressed level of SHBG. 25 Hyperinsulinaemic insulin resistance is thought to play an important role in the aetiology of PCOS and may be related to the hyperandrogenaemia observed in these patients. 4, 9 Many investigators have shown that impaired insulin sensitivity may be a feature of PCOS. 5, 13, 14, 18, 20, 22 We observed positive correlations between leptin and serum E 2 levels, LH levels and testosterone levels, in agreement with Mendonça et al. 1 It appears, therefore, that leptin can play a role in affecting gonadotropin levels, resulting in reproductive disorders in women with PCOS. 1, 10 In women with PCOS, we found a strong positive correlation between serum levels of insulin and LH. Hyperinsulinaemia results in an increase in both LH release and androgen production with subsequent alterations in follicle growth. 25 In agreement with other findings, 3, 18, 22, 26 serum HDL cholesterol levels were significantly lower in women with PCOS, probably because the insulin resistance might be increased and most patients were still hyperinsulinaemic. We did not, however, find any changes in the levels of serum TG, total cholesterol and LDL cholesterol. Similar findings were reported by Mendonça et al. 1 Lipoprotein abnormalities appear to be associated more with insulin than with endogenous androgens or oestrogens. 2, 3 The present study indicates that, in women with PCOS, a combination of certain risk factors (increased Lp[a] level and reduced HDL-cholesterol and ApoA-1 levels) may lead to the atherosclerotic process in decidual vessels. Studies have found serum homocysteine levels to be elevated in PCOS women, suggesting that an alteration in homocysteine metabolism might play a role in the increased cardiovascular risk associated with PCOS. 12 In the present study, elevated serum levels of homocysteine were found in our PCOS patients, which is similar to reports by some other investigators. 12, 14, 15, 27 We found a significant positive correlation between homocysteine and androstenedione and between homocysteine and insulin resistance, in agreement with Vrbikova et al. 27 Thus, hyperhomocysteinaemia seems to be directly related to atherogenesis, hence, high homocysteine levels may be useful in identifying the subgroup of PCOS women who are at risk for the subsequent development of atherosclerosis. Further longitudinal studies are needed to investigate this possibility. Badawy et al. 15 reported that insulin resistance and hyperhomocysteinaemia contributed to the long-term complications of PCOS. In another study, Vrbikova et al. 27 concluded that homocysteine was increased in women with PCOS and that it might be linked to androgen levels, but not to markers of insulin resistance or with lipid metabolism.
Leptin and homocysteine in PCOS
A study of obese patients with PCOS showed higher insulin, testosterone and LH concentrations in comparison with the other groups, but there was no difference in serum leptin, IGF-1 and SHBG levels. 28 In our study, serum levels of IGF-1 and IGFBP-3 were higher in women with PCOS compared with healthy women. An increase in IGF-1 bioavailability to the ovaries might stimulate androgen secretion 5, 29 and some studies have shown that high levels of IGF-1 stimulate LDL oxidation, resulting in atherogenesis. 7, 8 In ovarian granulosa cells, IGF-1 stimulates oestrogen production directly and synergistically with FSH by controlling aromatase levels. 5, 30 In theca cells, IGF-1 stimulates androgen secretion A Atamer, B Demir, G Bayhan et al.
synergistically with LH. 5, 31 Our findings indicate that women with PCOS and high IGF-1 and IGFBP-3 levels tend to have raised androgen and oestrogen levels.
The present study has shown that the risk of developing early atherosclerosis is increased in women with PCOS compared with healthy women. The early identification of coronary artery disease in PCOS might be advantageous in terms of early preventative measures. Our results suggest that hyperleptinaemia is associated with hyperandrogenaemia in women with
PCOS.
They also indicate that hyperhomocysteinaemia influences clinical and biochemical variables related to hyperandrogenism and insulin resistance. Both leptin and homocysteine might be involved in the pathophysiology of PCOS. These findings suggest that PCOS patients might have increased coronary artery risk factors.
